Compare VERA & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | HTH |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.1B |
| IPO Year | 2021 | 2003 |
| Metric | VERA | HTH |
|---|---|---|
| Price | $39.93 | $34.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $81.30 | $37.50 |
| AVG Volume (30 Days) | ★ 968.6K | 314.9K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ 51.72 |
| EPS | N/A | ★ 2.64 |
| Revenue | N/A | ★ $152,188,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $445.28 | $3.07 |
| P/E Ratio | ★ N/A | $13.21 |
| Revenue Growth | N/A | ★ 15.52 |
| 52 Week Low | $18.53 | $27.35 |
| 52 Week High | $56.05 | $40.41 |
| Indicator | VERA | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 31.12 |
| Support Level | $19.84 | $34.27 |
| Resistance Level | $56.05 | $35.69 |
| Average True Range (ATR) | 2.29 | 0.98 |
| MACD | 0.16 | -0.45 |
| Stochastic Oscillator | 39.02 | 1.68 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Hilltop Holdings Inc is a Dallas-based financial holding company. The company has three segments: The banking segment includes the operations of the Bank; The broker-dealer segment includes the operations of Securities Holdings,; and the mortgage origination segment is composed of PrimeLending. Majority of revenue is from Broker-dealer Segment.